Abstract
Argatroban in the managment of patients with heparin-induced thrombocytopenia type II (HIT) undergoing implantation of a left ventricular assist device. An institutional experience
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
